These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 37844061)
1. Investigation of the Diagnostic Value of sFLC and Other Indicators in the Detection of M Protein in LCMM. Wang J; Zhao Y; Ren Z; Sun A; Huang Z; Li X Clin Lab; 2023 Oct; 69(10):. PubMed ID: 37844061 [TBL] [Abstract][Full Text] [Related]
2. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains. Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834 [TBL] [Abstract][Full Text] [Related]
3. [Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma]. Song P; An ZM; Zhou XG; Li F; Wang LP; Zhao Q; Yu YP; Zhai YP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1357-61. PubMed ID: 26524037 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of three serum-free light-chain detection systems in the diagnosis of multiple myeloma. Zhu G; Fu X; Ren Y; Wang Y; Wang S; An G Int J Lab Hematol; 2022 Jun; 44(3):576-581. PubMed ID: 35060324 [TBL] [Abstract][Full Text] [Related]
5. Combined analysis using extended renal reference range of serum free light chain ratio and serum protein electrophoresis improves the diagnostic accuracy of multiple myeloma in renal insufficiency. Park JW; Kim YK; Bae EH; Ma SK; Kim SW Clin Biochem; 2012 Jul; 45(10-11):740-4. PubMed ID: 22503879 [TBL] [Abstract][Full Text] [Related]
6. [Two Serum Free Light Chain Detection Systems in the Diagnosis of Multiple Myeloma]. Zhu GQ; Fu X; Ren YS; Wang YS; Wang SL; Wang LC; Lin J; An G Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1209-1215. PubMed ID: 34362504 [TBL] [Abstract][Full Text] [Related]
7. [The Value of sFLC and Serum Calcium in the Diagnosis and Prognosis of Multiple Myeloma Patients]. Pei XH; Zhang LN; Zhou P; Wang TB; Lian C; Zhang P; Lei PC; Zhu ZM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):794-798. PubMed ID: 38926969 [TBL] [Abstract][Full Text] [Related]
8. [The prognostic value of baseline serum free light chain in immunoglobulin light-chain cardiac amyloidosis]. Wang LM; Wang TT; Tian Y; Zhao L; Yang XC; Chen WM Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):47-53. PubMed ID: 32023754 [No Abstract] [Full Text] [Related]
9. Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma. Dejoie T; Corre J; Caillon H; Hulin C; Perrot A; Caillot D; Boyle E; Chretien ML; Fontan J; Belhadj K; Brechignac S; Decaux O; Voillat L; Rodon P; Fitoussi O; Araujo C; Benboubker L; Fontan C; Tiab M; Godmer P; Luycx O; Allangba O; Pignon JM; Fuzibet JG; Legros L; Stoppa AM; Dib M; Pegourie B; Orsini-Piocelle F; Karlin L; Arnulf B; Roussel M; Garderet L; Mohty M; Meuleman N; Doyen C; Lenain P; Macro M; Leleu X; Facon T; Moreau P; Attal M; Avet-Loiseau H Blood; 2016 Dec; 128(25):2941-2948. PubMed ID: 27729323 [TBL] [Abstract][Full Text] [Related]
10. [The prognostic value of baseline serum free light chain in cardiac amyloidosis]. Zhao L; Tian Z; Fang Q Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):186-90. PubMed ID: 26926369 [TBL] [Abstract][Full Text] [Related]
11. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma]. Zhao D; Jiang JQ; Lin L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375 [TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [TBL] [Abstract][Full Text] [Related]
13. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications. Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation and comparison of prognostic value of serum free light chain ratio/difference in patients with newly diagnosed multiple myeloma]. Li L; Jiang H; Fu WJ; Du J; He HY; Lu J; An R; He J; Zhang H; Zhao YY; Wu H; Hou J Zhonghua Xue Ye Xue Za Zhi; 2019 Apr; 40(4):321-326. PubMed ID: 31104445 [No Abstract] [Full Text] [Related]
15. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof]. Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880 [TBL] [Abstract][Full Text] [Related]
17. The association of serum-free light-chain levels with markers of renal function. Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734 [TBL] [Abstract][Full Text] [Related]
18. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies. Cao F; Zhang R; Xu L; Liu M; Yuan Y Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571 [TBL] [Abstract][Full Text] [Related]
19. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders. Vermeersch P; Vercammen M; Holvoet A; Vande Broek I; Delforge M; Bossuyt X Clin Chim Acta; 2009 Dec; 410(1-2):54-8. PubMed ID: 19778527 [TBL] [Abstract][Full Text] [Related]
20. Serum Free Light Chain Predict Overall Survival and Response to Therapy in Patients with Newly Diagnosed Multiple Myeloma. Meddour Y; Rahali MC; Belakehal SE; Ardjoun FZ; Chaib S; Djidjik R Clin Lab; 2018 Apr; 64(4):551-558. PubMed ID: 29739080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]